The ColoFuture study, a multi-center international clinical trial assessing the potential to integrate a portfolio of novel mRNA biomarkers into ColoAlert, has demonstrated positive topline results.
New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that one’s biological age, which can be higher than his or her chronological age – a concept called accelerated aging – may predict who’s at risk for developing colon polyps, a known risk factor for colorectal cancer.
